Metopirone
Active substance: metyrapone
CAPSULE, GELATIN COATED · METYRAPONE 250 mg/1
United StatesActive
Marketing holder: HRA Pharma Rare Diseases
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- METYRAPONE · 250 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-2227-7cde-a0a3-be1b4faee347,01a1209b-a500-7926-97e1-49cd8690ebdc;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 76336-455
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 76336-455 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76336-455 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76336-455 · Verified 2026-10-09 · open in source